Cargando…

Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge

AIM: This study attempted to distinguish primary bladder adenocarcinoma (PBA) from metastatic colonic adenocarcinomas (MCA), which is a difficult diagnostic and clinical problem. METHODS: Twenty-four cases of bladder adenocarcinomas (12 primary & 12 metastatic colorectal) were included in the st...

Descripción completa

Detalles Bibliográficos
Autores principales: Roy, Somak, Smith, Matthew A, Cieply, Kathy M, Acquafondata, Marie B, Parwani, Anil V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502416/
https://www.ncbi.nlm.nih.gov/pubmed/23121893
http://dx.doi.org/10.1186/1746-1596-7-151
_version_ 1782250333621190656
author Roy, Somak
Smith, Matthew A
Cieply, Kathy M
Acquafondata, Marie B
Parwani, Anil V
author_facet Roy, Somak
Smith, Matthew A
Cieply, Kathy M
Acquafondata, Marie B
Parwani, Anil V
author_sort Roy, Somak
collection PubMed
description AIM: This study attempted to distinguish primary bladder adenocarcinoma (PBA) from metastatic colonic adenocarcinomas (MCA), which is a difficult diagnostic and clinical problem. METHODS: Twenty-four cases of bladder adenocarcinomas (12 primary & 12 metastatic colorectal) were included in the study with urothelial carcinoma (UC) and colonic adenocarcinoma (CA) as controls. A panel of immunohistochemical (IHC) stains along with fluorescence in-situ hybridization (FISH), using the UroVysion probe set, was performed. RESULTS: The majority of the PBAs presented with advanced disease. Enteric histologic subtype was the most common morphological variant. Strong nuclear with cytoplasmic-membranous staining of β-catenin was seen in 75% of MCA and only 16.7% PBA (<10% staining cells). Although abnormal nuclear staining with E-cadherin was seen in both PBA and MCA, it was more frequent in former. CK-7, CK-20, villin and CDX-2 stains were not helpful in distinguishing the two entities. FISH did not reveal any unique differences in chromosomal abnormality between the two groups. CONCLUSION: Although there was a statistically significant difference in β-catenin and E-cadherin staining between two groups, we did not find any IHC or FISH marker that was specific for PBA. Distinction between PBA and MCA remains a diagnostic problem and clinical correlation is vital before rendering a diagnosis. VIRTUAL SLIDES: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1393156268152357
format Online
Article
Text
id pubmed-3502416
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35024162012-11-21 Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge Roy, Somak Smith, Matthew A Cieply, Kathy M Acquafondata, Marie B Parwani, Anil V Diagn Pathol Research AIM: This study attempted to distinguish primary bladder adenocarcinoma (PBA) from metastatic colonic adenocarcinomas (MCA), which is a difficult diagnostic and clinical problem. METHODS: Twenty-four cases of bladder adenocarcinomas (12 primary & 12 metastatic colorectal) were included in the study with urothelial carcinoma (UC) and colonic adenocarcinoma (CA) as controls. A panel of immunohistochemical (IHC) stains along with fluorescence in-situ hybridization (FISH), using the UroVysion probe set, was performed. RESULTS: The majority of the PBAs presented with advanced disease. Enteric histologic subtype was the most common morphological variant. Strong nuclear with cytoplasmic-membranous staining of β-catenin was seen in 75% of MCA and only 16.7% PBA (<10% staining cells). Although abnormal nuclear staining with E-cadherin was seen in both PBA and MCA, it was more frequent in former. CK-7, CK-20, villin and CDX-2 stains were not helpful in distinguishing the two entities. FISH did not reveal any unique differences in chromosomal abnormality between the two groups. CONCLUSION: Although there was a statistically significant difference in β-catenin and E-cadherin staining between two groups, we did not find any IHC or FISH marker that was specific for PBA. Distinction between PBA and MCA remains a diagnostic problem and clinical correlation is vital before rendering a diagnosis. VIRTUAL SLIDES: The virtual slides for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1393156268152357 BioMed Central 2012-11-02 /pmc/articles/PMC3502416/ /pubmed/23121893 http://dx.doi.org/10.1186/1746-1596-7-151 Text en Copyright ©2012 Roy et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Roy, Somak
Smith, Matthew A
Cieply, Kathy M
Acquafondata, Marie B
Parwani, Anil V
Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
title Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
title_full Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
title_fullStr Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
title_full_unstemmed Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
title_short Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
title_sort primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502416/
https://www.ncbi.nlm.nih.gov/pubmed/23121893
http://dx.doi.org/10.1186/1746-1596-7-151
work_keys_str_mv AT roysomak primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge
AT smithmatthewa primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge
AT cieplykathym primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge
AT acquafondatamarieb primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge
AT parwanianilv primarybladderadenocarcinomaversusmetastaticcolorectaladenocarcinomaapersistingdiagnosticchallenge